Ventas portfolio sees 5 consecutive months of occupancy growth: CEO
By
Kimberly Bonvissuto
Aug 09, 2021
Ventas Chairman and CEO Debra Cafaro said Friday that she sees a clear path to growth for the Chicago-based real estate investment trust and is committed to “winning the recovery.”
Pfizer has two updated booster shots to help fight omicron
Jun 27, 2022
The company said Saturday that it was confident that its new booster candidates are better than their predecessor.
Potential safety concern for Guillain-Barré syndrome ID’d for Ad26.COV2.S
Oct 18, 2021
Receipt of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccine is associated with a potential small, but statistically significant, safety concern for Guillain-Barré syndrome (GBS), according...
Holiday announces COVID shot mandate one day after full approval of Pfizer vaccine
By
Lois A. Bowers
Aug 25, 2021
The country’s largest independent living operator, Winter Park, FL-based Holiday Retirement, is requiring its more than 6,300 employees to receive their first COVID-19 vaccine by Oct. 4, the company...
Third, fourth COVID-19 vaccine doses boost humoral response in seniors
Jul 27, 2022
Third and fourth doses were tied to significantly increased anti-S IgG titers in older adults, but optimal timing of additional doses is not known.
Last week, the White House said local pharmacies are now providing more than two-thirds of COVID-19 vaccinations.
COVID-19 booster compliance among long-term care workers remains low
By
Kathleen Steele Gaivin
Apr 15, 2022
New Jersey Gov. Phil Murphy (D) this week clarified that long-term care and other healthcare workers in the state satisfy the state’s vaccination requirements once they obtain one booster dose of a COVID-19...
Fourth dose of BNT162b2 offers protection against severe COVID-19
Apr 08, 2022
Protection against COVID-19 did not wane in six weeks after receipt of fourth dose of the Pfizer–BioNTech vaccine; protection against the infection waned.
Third mRNA vaccine dose ups effectiveness against hospitalization
Jan 27, 2022
Vaccine effectiveness against COVID-19 hospitalization is increased with a third dose in those with or without immunocompromising conditions.
No increase seen in CV events in elderly after BNT162b2 vaccination
Dec 10, 2021
No increase was seen in the incidence of myocardial infarction, stroke or pulmonary embolism among those aged 75 years or older in France.